Cardiac Rhythm Management Devices - Global Market Outlook (2018-2027)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,150	170 Pages	Stratistics Market Research Consulting	December, 2019	SMR16110899

Best Price Guarantee
Price	from $4,150
Length	170 Pages
Publisher	Stratistics Market Research Consulting
Published Date	December, 2019
SKU	SMR16110899

Cardiac Rhythm Management Devices - Global Market Outlook (2018-2027)

According to Stratistics MRC, the Global Cardiac Rhythm Management Devices Market is accounted for $20.32 billion in 2018 and is expected to reach $42.78 billion by 2027 growing at a CAGR of 8.6% during the forecast period. Increasing awareness regarding cardiac disorders, rising demand for implantable cardioverter-defibrillator devices in developing economies and growing geriatric population base coupled with the rising prevalence of obesity are some of the factors fuelling the market growth. However, High cost of devices and Complications of CRT in children is restricting the market growth.

Cardiac rhythm management is a treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmia causes palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices include pacemakers, cardiac resynchronization therapy devices, and implantable cardiac defibrillators.

Based on the product, the cardiac resynchronization therapy (CRT) segment is anticipated to register lucrative growth over the forecast period. The growth of CRT devices is majorly due to the rising prevalence of heart failure witnessed across the globe. Moreover, Growing number of geriatric population across the globe along with the rising incidence of atrial fibrillation, arrhythmias, congenital heart diseases are some other factors that have augmented the need and demand for resynchronization therapy devices products.

By Geography, North America is expected to have a significant market growth during the forecast period, owing to increasing incidence rate of cardiovascular diseases across various countries in the region, increasing elderly population, ready acceptance of technological advanced products (long battery life, biocompatible materials or miniaturization, & leadless) and increasing regulatory approvals.

Some of the key players profiled in the Cardiac Rhythm Management Devices market include Abiomed, Inc., Defibtech, LLC., Boston Scientific Corporation, SCHILLER AG, Stryker, Koninklijke Philips N.V., Medtronic plc, General Electric (GE) Company, LivaNova PLC, Cardiac Science Corporation, Hill-Rom Holdings, Inc., Biotronik SE & Co. KG, Berlin Heart GmbH, Abbott Laboratories, St. Jude Medical, and Altera.

Products Covered:
• Defibrillator
• Cardiac Resynchronization Therapy (CRT)
• Pacemakers
• Accessories
• Other Products

Applications Covered:
• Bradycardia
• Heart Failure
• Tachycardia
• Other Applications

End Users Covered:
• Hospitals & Clinics
• Home Care Settings
• Ambulatory Surgery Centers
• Cardiac Centers
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary
2 Preface: 2.1 Abstract; 2.2 Stake Holders; 2.3 Research Scope; 2.4 Research Methodology; 2.4.1 Data Mining; 2.4.2 Data Analysis; 2.4.3 Data Validation; 2.4.4 Research Approach; 2.5 Research Sources; 2.5.1 Primary Research Sources; 2.5.2 Secondary Research Sources; 2.5.3 Assumptions
3 Market Trend Analysis: 3.1 Introduction; 3.2 Drivers; 3.3 Restraints; 3.4 Opportunities; 3.5 Threats; 3.6 Product Analysis; 3.7 Application Analysis; 3.8 End User Analysis; 3.9 Emerging Markets; 3.10 Futuristic Market Scenario
4 Porters Five Force Analysis: 4.1 Bargaining power of suppliers; 4.2 Bargaining power of buyers; 4.3 Threat of substitutes; 4.4 Threat of new entrants; 4.5 Competitive rivalry
5 Global Cardiac Rhythm Management Devices Market, By Product: 5.1 Introduction; 5.2 Defibrillator; 5.2.1 External Defibrillator (ED); 5.2.1.1 Automated External Defibrillators (AEDs); 5.2.1.1.1 Fully Automated External Defibrillator; 5.2.1.1.2 Semi-automated External Defibrillator; 5.2.1.2 Manual External Defibrillators; 5.2.1.3 Wearable Cardioverter Defibrillator; 5.2.2 Implantable Cardioverter Defibrillators (ICDs); 5.2.2.1 Transvenous ICD (T-ICD); 5.2.2.1.1 Dual-chamber ICDs; 5.2.2.1.2 Biventricular ICDs; 5.2.2.1.3 Single-chamber ICDs; 5.2.2.2 Subcutaneous ICD (S-ICD); 5.3 Cardiac Resynchronization Therapy (CRT); 5.3.1 CRT-Defibrillators (CRT-Ds); 5.3.2 CRT-Pacemakers (CRT-Ps); 5.4 Pacemakers; 5.4.1 Single Chamber Cardiac Pacemaker; 5.4.2 Bi Ventricular Pacemakers; 5.4.3 Dual Chamber Cardiac Pacemaker; 5.4.4 Leadless Pacemaker; 5.4.5 Implantability; 5.4.5.1 Implantable Pacemakers; 5.4.5.2 External Pacemakers; 5.4.6 Traditional Pacemaker; 5.5 Accessories; 5.5.1 Defibrillation Leads; 5.5.2 Pacing Leads; 5.6 Other Products
6 Global Cardiac Rhythm Management Devices Market, By Application: 6.1 Introduction; 6.2 Bradycardia; 6.3 Heart Failure; 6.4 Tachycardia; 6.5 Other Applications
7 Global Cardiac Rhythm Management Devices Market, By End User: 7.1 Introduction; 7.2 Hospitals & Clinics; 7.3 Home Care Settings; 7.4 Ambulatory Surgery Centers; 7.5 Cardiac Centers; 7.6 Other End Users
8 Global Cardiac Rhythm Management Devices Market, By Geography: 8.1 Introduction; 8.2 North America; 8.2.1 US; 8.2.2 Canada; 8.2.3 Mexico; 8.3 Europe; 8.3.1 Germany; 8.3.2 UK; 8.3.3 Italy; 8.3.4 France; 8.3.5 Spain; 8.3.6 Rest of Europe; 8.4 Asia Pacific; 8.4.1 Japan; 8.4.2 China; 8.4.3 India; 8.4.4 Australia; 8.4.5 New Zealand; 8.4.6 South Korea; 8.4.7 Rest of Asia Pacific; 8.5 South America; 8.5.1 Argentina; 8.5.2 Brazil; 8.5.3 Chile; 8.5.4 Rest of South America; 8.6 Middle East & Africa; 8.6.1 Saudi Arabia; 8.6.2 UAE; 8.6.3 Qatar; 8.6.4 South Africa; 8.6.5 Rest of Middle East & Africa
9 Key Developments: 9.1 Agreements, Partnerships, Collaborations and Joint Ventures; 9.2 Acquisitions & Mergers; 9.3 New Product Launch; 9.4 Expansions; 9.5 Other Key Strategies
10 Company Profiling: 10.1 Abiomed, Inc.; 10.2 Defibtech, LLC.; 10.3 Boston Scientific Corporation; 10.4 SCHILLER AG; 10.5 Stryker; 10.6 Koninklijke Philips N.V.; 10.7 Medtronic plc; 10.8 General Electric (GE) Company; 10.9 LivaNova PLC; 10.10 Cardiac Science Corporation; 10.11 Hill-Rom Holdings, Inc.; 10.12 Biotronik SE & Co. KG; 10.13 Berlin Heart GmbH; 10.14 Abbott Laboratories; 10.15 St. Jude Medical; 10.16 Altera
List of Tables: Table 1 Global Cardiac Rhythm Management Devices Market Outlook, By Region (2017-2027) ($MN); Table 2 Global Cardiac Rhythm Management Devices Market Outlook, By Product (2017-2027) ($MN); Table 3 Global Cardiac Rhythm Management Devices Market Outlook, By Defibrillator (2017-2027) ($MN); Table 4 Global Cardiac Rhythm Management Devices Market Outlook, By External Defibrillator (ED) (2017-2027) ($MN); Table 5 Global Cardiac Rhythm Management Devices Market Outlook, By Implantable Cardioverter Defibrillators (ICDs) (2017-2027) ($MN); Table 6 Global Cardiac Rhythm Management Devices Market Outlook, By Cardiac Resynchronization Therapy (CRT) (2017-2027) ($MN); Table 7 Global Cardiac Rhythm Management Devices Market Outlook, By CRT-Defibrillators (CRT-D) (2017-2027) ($MN); Table 8 Global Cardiac Rhythm Management Devices Market Outlook, By CRT-Pacemakers (CRT-P) (2017-2027) ($MN); Table 9 Global Cardiac Rhythm Management Devices Market Outlook, By Pacemakers (2017-2027) ($MN); Table 10 Global Cardiac Rhythm Management Devices Market Outlook, By Single Chamber Cardiac Pacemaker (2017-2027) ($MN); Table 11 Global Cardiac Rhythm Management Devices Market Outlook, By Bi Ventricular Pacemakers (2017-2027) ($MN); Table 12 Global Cardiac Rhythm Management Devices Market Outlook, By Dual Chamber Cardiac Pacemaker (2017-2027) ($MN); Table 13 Global Cardiac Rhythm Management Devices Market Outlook, By Leadless Pacemaker (2017-2027) ($MN); Table 14 Global Cardiac Rhythm Management Devices Market Outlook, By Implantability (2017-2027) ($MN); Table 15 Global Cardiac Rhythm Management Devices Market Outlook, By Traditional Pacemaker (2017-2027) ($MN); Table 16 Global Cardiac Rhythm Management Devices Market Outlook, By Accessories (2017-2027) ($MN); Table17 Global Cardiac Rhythm Management Devices Market Outlook, By Defibrillation Leads (2017-2027) ($MN); Table 18 Global Cardiac Rhythm Management Devices Market Outlook, By Pacing Leads (2017-2027) ($MN); Table 19 Global Cardiac Rhythm Management Devices Market Outlook, By Other Products (2017-2027) ($MN); Table 20 Global Cardiac Rhythm Management Devices Market Outlook, By Application (2017-2027) ($MN); Table 21 Global Cardiac Rhythm Management Devices Market Outlook, By Bradycardia (2017-2027) ($MN); Table 22 Global Cardiac Rhythm Management Devices Market Outlook, By Heart Failure (2017-2027) ($MN); Table 23 Global Cardiac Rhythm Management Devices Market Outlook, By Tachycardia (2017-2027) ($MN); Table 24 Global Cardiac Rhythm Management Devices Market Outlook, By Other Applications (2017-2027) ($MN); Table 25 Global Cardiac Rhythm Management Devices Market Outlook, By End User (2017-2027) ($MN); Table 26 Global Cardiac Rhythm Management Devices Market Outlook, By Hospitals & Clinics (2017-2027) ($MN); Table 27 Global Cardiac Rhythm Management Devices Market Outlook, By Home Care Settings (2017-2027) ($MN); Table 28 Global Cardiac Rhythm Management Devices Market Outlook, By Ambulatory Surgery Centers (2017-2027) ($MN); Table 29 Global Cardiac Rhythm Management Devices Market Outlook, By Cardiac Centers (2017-2027) ($MN); Table 30 Global Cardiac Rhythm Management Devices Market Outlook, By Other End Users (2017-2027) ($MN); Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.